Synartro AB
PrivateLast Round
VC Round
Oct 9, 2024
Total Funding Raised
$6.36M
Company Overview
Synartro AB is a life science company that develops local injection treatments for osteoarthritis by combining proprietary slow-release technology with existing proven drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synartro AB Comparables
Compare Synartro AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eupraxia Pharmaceuticals Inc. | 78% | |
| Relevium Medical | 76% | |
| TLC BioSciences Corp. | 75% | |
Synartro AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 9, 2024 | ||||
| Convertible Debt | Oct 9, 2024 | ||||
| Series A | Oct 25, 2021 | ||||
| Seed | Oct 2, 2020 |
Synartro AB Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2024
$1.35M round led by Linc AB and Sciety
- Oct 9, 2024
$529K raised from Linc AB and Sciety
Synartro AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synartro AB's valuation, stock price, and market status.